Cart
sales@molnova.com
Platelet-Derived Growth Factor Receptor Substrate 1
CAS No. ———
Platelet-Derived Growth Factor Receptor Substrate 1( ——— )
Catalog No. M41568 CAS No. ———
Platelet-Derived Growth Factor Receptor Substrate 1; PDGF Receptor Substrate
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePlatelet-Derived Growth Factor Receptor Substrate 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionPlatelet-Derived Growth Factor Receptor Substrate 1; PDGF Receptor Substrate
-
DescriptionPlatelet-Derived Growth Factor Receptor Substrate 1; PDGF Receptor Substrate
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight———
-
Molecular Formula———
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
(3β,4α,7β,15α)-3,7,1...
3β,7β,15α-Trihydroxy-4-(hydroxymethyl)-11,23-dioxo-lanost-8-en-26-oic acid is a triterpene compound that can be found in Ganoderma lucidum, and it inhibits nitric oxide (NO) production in BV-2 microglial cells induced by lipopolysaccharide (LPS), with an IC50 of 4.15 μM.
-
Xylopentaose
Xylopentaose consists of five b-14 xylose sugars.
-
Cenobamate
Cenobamate (YKP-3089, YKP3089) is a potential anti-seizure agent with currently unknown mechanisms of action.
